TOIIW (The Oncology Institute) Change In Inventory: $-11.98 Mil (TTM As of Mar. 2026)


TOIIW The Oncology Institute Inc TOIIW
61 GF Score
Price $0.06
! 6 Warning Signs
View Full Analysis

What is The Oncology Institute Change In Inventory?

The Oncology Institute TOIIW 61 Change In Inventory is $-11.98 Mil as of Mar. 2026. GuruFocus rates TOIIW with a GF Score™ of 61/100. The stock has 6 warning signs investors should review.

The Oncology Institute's change in inventory for the quarter that ended in Mar. 2026 was $-7.42 Mil. It means The Oncology Institute's inventory increased by $7.42 Mil from Dec. 2025 to Mar. 2026 .

The Oncology Institute's change in inventory for the fiscal year that ended in Dec. 2025 was $-6.84 Mil. It means The Oncology Institute's inventory increased by $6.84 Mil from Dec. 2024 to Dec. 2025 .

The Oncology Institute's Total Inventories for the quarter that ended in Mar. 2026 was $24.29 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. The Oncology Institute's Days Inventory for the quarter that ended in Mar. 2026 was 15.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. The Oncology Institute's Inventory Turnover for the quarter that ended in Mar. 2026 was 6.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. The Oncology Institute's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.14.

The Oncology Institute  (NAS:TOIIW) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

The Oncology Institute's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=20.5825/124.126*365 / 4
=15.13

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

The Oncology Institute's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=124.126 / 20.5825
=6.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

The Oncology Institute's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=20.5825 / 147.441
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute Change In Inventory Related Terms

The Oncology Institute Change In Inventory Historical Data

* Premium members only.

The historical data trend for The Oncology Institute's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute Change In Inventory Chart

The Oncology Institute Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -1.84 -1.73 -4.39 3.64 -6.84

The Oncology Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.27 -3.48 -3.10 2.01 -7.42
TOIIW
61GF Score
The Oncology Institute Inc TOIIW
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Oncology Institute Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-11.98 Mil mean?
The Oncology Institute (TOIIW) has a Change In Inventory of $-11.98 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for The Oncology Institute and its competitors.
Is The Oncology Institute's Change In Inventory too high?
The Oncology Institute's current Change In Inventory is $-11.98 Mil. Overall, The Oncology Institute has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does The Oncology Institute's Change In Inventory compare to CYH and SRTA?
The Oncology Institute's Change In Inventory of $-11.98 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Healthcare Providers & Services company?
A good Change In Inventory depends on the Healthcare Providers & Services industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for The Oncology Institute and its competitors. The Oncology Institute's current Change In Inventory is $-11.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Oncology Institute stock overvalued right now?
The Oncology Institute (TOIIW) has a current Change In Inventory of $-11.98 Mil. The current Change In Inventory is $-11.98 Mil. The Oncology Institute's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For The Oncology Institute (TOIIW), the current Change In Inventory is $-11.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Oncology Institute Business Description

Other Exchanges TOI:USA
Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
61GF Score

Get the complete analysis for TOIIW

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price